| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/MOL.0000000000000318 |
| P698 | PubMed publication ID | 27213628 |
| P50 | author | Jonathan D Schofield | Q38548429 |
| Safwaan Adam | Q47377916 | ||
| P2093 | author name string | Paul N Durrington | |
| Handrean Soran | |||
| P433 | issue | 4 | |
| P921 | main subject | dyslipidemia | Q66291209 |
| P304 | page(s) | 313-322 | |
| P577 | publication date | 2016-08-01 | |
| P1433 | published in | Current Opinion in Lipidology | Q15758705 |
| P1476 | title | Diabetic dyslipidaemia | |
| P478 | volume | 27 |
| Q55516148 | Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy. |
| Q49592460 | Hypercholesterolaemia - practical information for non-specialists |
| Q91605333 | Intestine-Specific Overexpression of Carboxylesterase 2c Protects Mice From Diet-Induced Liver Steatosis and Obesity |
| Q48255876 | Laparoscopic Roux-En-Y Gastric Bypass Improves Lipid Profile and Decreases Cardiovascular Risk: a 5-Year Longitudinal Cohort Study of 1048 Patients |
| Q42323374 | Metabolic and Cardiovascular Benefits and Risks of EMD386088-A 5-HT6 Receptor Partial Agonist and Dopamine Transporter Inhibitor |
| Q91619649 | More aggressive lipid lowering in people with diabetes? |
| Q28076399 | Omega-3 carboxylic acids monotherapy and combination with statins in the management of dyslipidemia |
| Q92510491 | Rhizoma coptidis as a Potential Treatment Agent for Type 2 Diabetes Mellitus and the Underlying Mechanisms: A Review |
| Q92259386 | The Systemic Redox Status Is Maintained in Non-Smoking Type 2 Diabetic Subjects Without Cardiovascular Disease: Association with Elevated Triglycerides and Large VLDL |
| Q40364483 | Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: The Strong Heart Study |
| Q55021969 | Usefulness of alirocumab and evolocumab for the treatment of patients with diabetic dyslipidemia. |
Search more.